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Abstract 
Despite their importance in the oversight of modern medical research, the history of 
Research Ethics Committees (RECs) in the UK has tended to be limited to a list of 
important events, rather than detailed exploration of how these bodies developed over 
time. This article uses archive material to highlight the importance of the Ministry of 
Health in the late 1960s, as it supported the Royal College of Physicians’ attempts to 
set up RECs, shape the interpretation of the College’s recommendations while at the 
same time attempting to remain at arms-length from these committees themselves. 
The central problem faced by the Ministry was the need for RECs to remain advisory 
bodies rather than formally part of hospital hierarchy, for fear of infringing on clinical 
autonomy and possibly making hospitals (and the broader NHS) liable for mistakes 
made during research. This paper traces the development of RECs from their origins 
to the announcement in 1972 of a study surveying these committees and their 
membership. 
 
Introduction 
Given the centrality of ethics review by independent committees (called Research 
Ethics Committees, or RECs, in the UK) to modern biomedical research and the 
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ubiquity of complaints about such review on the part of researchers1, it is curious that 
little attention has been paid to these organisations by medical historians2 in contrast 
to the work looking at the role of institutions such as the BMA and GMC in the 
development of medical professional ethics
3
, and the general development of medical 
                                                 
1
 Robinson L, Murdoch-Eaton D and Carter Y ‘Editorial: NHS research ethics committees’ British 
Medical Journal, 2007, 335: 6; Wainwright P and Saunders J ‘What are local issues? The problems of 
the local review of research’ Journal of Medical Ethics, 2004,  30: 313-317; Martyn C ‘The ethical 
bureaucracy’ Quarterly Journal of Medicine, 2003, 96:323-324; Chalmers I ‘Letter: Lessons for 
research ethics committees’ The Lancet, 2002, 359:174; Dunn NR, Arscott A and Mann RD ‘Costs of 
seeking ethics approval before and after the introduction of multicentre research ethics committees’ 
Journal of the Royal Society of Medicine, 2000, 93:511-512; Stacey TE ‘Ethical review of research in 
the NHS: the need for change’ Journal of the Royal College of Physicians of London, 1998, 32(3): 190-
192; While AE ‘Research ethics committees at work’ Journal of Medical Ethics, 1996, 22:352-355; 
Eichler H ‘Letter: Hazards of misguided ethics committees’ The Lancet, 1995, 346: 1115-1116; Harries 
U.J. et al ‘Local research ethics committees: Widely differing responses to a national survey protocol’ 
Journal of the Royal College of Physicians of London, 1994, 28(2): 150-154; Watling MIL and 
Dewhurst JK ‘Current experience of central versus local ethics approval in multicentre studies’ Journal 
of the Royal College of Physicians of London, 1993, 27(4): 399-402; Berry T.J., Ades T. and Peckham 
C  ‘Letter: Too many ethics committees’ British Medical Journal¸1990, 301: 1274; Anon. ‘Editorial: 
Research Ethics Committees’ The Lancet, 1983, May 7, p.1026; Lewis PJ ‘The drawbacks of research 
ethics committees’ Journal of medical ethics, 1982, 8:61-64.  
2
 The best work on the context and early stages of REC development is offered by Jenny Hazelgrove: 
Hazelgrove J ‘The Old Faith and the New Science: The Nuremberg Code and Human Experimentation 
Ethics in Britain, 1946–73’ Social History of Medicine, 2002, 15(1): 109-135; Hazelgrove J ‘British 
research ethics after the second world war: the controversy at the British Postgraduate Medical School, 
Hammersmith Hospital’, in V Roelcke and G Maio (eds.) Twentieth Century Ethics of Human Subjects 
Research, Stuttgart, Fran Steiner Verlag, 2004, pp. 181-197 
3
 Smith RG ‘The development of ethical guidance for medical practitioners by the general medical 
council’ Medical History, 1993, 37:56-67; Morrice A ‘ “Honour and interests”: medical ethics and the 
 4 
professionals’ ethical values.4 Thus while some work has explored the origins of 
modern medical ethics teaching in the UK
5
 and the parallel development of academic 
bioethics
6
 very little attention has been paid to how the specific institution of 
Research Ethics Committees were set up and developed in the late 1960s and early 
1970s.  
 
Although some scholars have discussed the development of the British REC system, 
this work tends to provide little beyond an outline of major events.
7
 These might 
include a report from the Royal College of Physicians (RCP) in 1967, the Department 
of Health’s ‘Red Book’ of 1991 outlining the responsibilities of Local Research 
Ethics Committees (LRECs) and more recently the development of multicentre RECs 
(MRECs) in 1997.  
 
This article explores in depth the role of the Ministry of Health in the early years of 
the REC system; although RECs were unknown in the UK in 1966, within six years 
                                                                                                                                            
British Medical Association’ in AH Maehle and J Geyer-Kordesch (eds.) Historical and Philosophical 
Perspectives on Biomedical Ethics, Aldershot, Ashgate 2002, pp. 11-33. 
4
 Waddington I ‘The development of medical ethics – A sociological analysis’ Medical History,  1975, 
19:36-51; Halpern S Lesser Harms: The Morality of Risk in Medical Research, Chicago, Chicago 
University Press, 2004. 
5
 Whong-Barr M ‘Clinical Ethics Teaching in Britain: a history of the London Medical Group’ New 
Review of Bioethics, 2003, 1(1): 73-84. 
6
 Cooter R ‘The Ethical Body’ in R. Cooter and JV Pickstone (eds.) Medicine in the Twentieth Century 
(Harwood), 2000, pp. 451-468. 
7
 Foster C The Ethics of Medical Research on Humans, Cambridge, Cambridge University Press, 2001, 
pp.140-146; Ashcroft R ‘The Ethics and Governance of Medical Research: what does regulation have 
to do with ethics?’ New Review of Bioethics, 2003, 1(1): 41-58. 
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Michael Alison, the Under-Secretary of State for Health and Social Security, could 
inform Parliament that all teaching hospitals and over 70 percent of other hospitals 
had set up such committees to oversee clinical research, a total of 238 RECs. What 
interests and forces underpinned the rapid expansion of organisations which, 
according to current thinking, are so inimical to the interests of biomedical 
researchers and doctors as a whole?
8
 How did such an expansion take place when the 
Ministry of Health deigned to formally get involved in setting the rules for their 
composition or acknowledging a role in their oversight? This latter point is of 
particular interest, since, as I will show, the Ministry, while remaining at arms length 
from the need to set up RECs and control their function, sought, through the actions 
of others’ such as the RCP and members of Parliament, and thorough controlled 
release of information to bodies such as the Patients Association, to maintain some 
semblance of control over ethics review policy, while at the same time balancing it 
with the need to remain ‘hands off’ with regard to clinical activities. 
 
Methodologically, this paper emphasises the need for nuanced, empirically detailed 
analysis in researching the role of institutions involved in research ethics. UK 
                                                 
8
 With regard to the impact on biomedical science see: Derbyshire SWG ‘The rise of the ethics 
committee: regulation by another name?’ in J Panton and OM Hartwich (eds.) Science vs. Superstition: 
the case for a new scientific enlightenment (Policy Exchange and University of Buckingham Press), 
2006, pp.35-50; Warlow C ‘Editorial: Clinical research is under the cosh again’ British Medical 
Journal, 2004, 329:241-242; Jamrozik K. ‘Research Ethics paperwork: what is the plot we seem to 
have lost?’ British Medical Journal, 2004, 329:286-7. Similar claims have been made about the impact 
of ethics review on social science: Dingwall R. ‘Editorial: An exercise in fatuity’ Journal of Health 
Services Research and Policy, 2006, 11(4): 193-194; Dingwall R. ‘ “Turn off the oxygen…” Comment 
on the presidential Address’ Law and Society Review, (2007), 41(4):787-795. 
 6 
Research Ethics Committees originated within the NHS, and to examine their 
development without taking due account of that context, is to fail to offer up a full 
explanation for how these bodies developed in the way they did. As well as 
emphasising context, such an approach also rejects what Laura Stark calls the ‘critical 
event’ model – roughly analogous to what has been called the ‘moral panic’ view of 
REC development
9
 – whereby the “simple fact that a scandal happened is used to 
explain subsequent developments in the human subjects review system”.10 The 
‘critical events’ approach would overlook the 1960s as a period of intense change and 
introspection on the part of the medical profession, as suggested by events both 
nationally (the setting up, in 1963, of the London Medical Group to teach medical 
ethics to students) and internationally (the World Medical Association’s Declaration 
of Helsinki of 1964).
11
  A key problem with the critical events model, with its focus 
on individuals, whistle blowers and scandals, and its avoidance of context and 
continuity in ethical thinking, is that it is exactly the approach offered by bioethicists 
to explain developments in this area
12
, and as such leads to histories that mirror, rather 
                                                 
9
 van den Hoonaard WC ‘Is research-ethics review a moral panic?’ The Canadian Review of Sociology 
and Anthropology, 2001, 38(1): 19-36; see also Fitzgerald MH ‘Punctuated equilibrium, moral panics 
and the ethics review process’ Journal of Academic Ethics, 2005, 2(4): 1-24. 
10
 Stark L ‘Morality in Science: How research is evaluated in the Age of human subject regulation’ 
Ph.D. Thesis, Princeton University, 2006, p.32 
11
 Whong-Barr op. cit. note 5; Lederer S.E. ‘Research without borders: the origins of the Declaration of 
Helsinki’ in , in V Roelcke and G Maio (eds.) Twentieth Century Ethics of Human Subjects Research, 
Stuttgart, Fran Steiner Verlag, 2004, pp. 199-217. 
12
 Jonsen AR The Birth of Bioethics, New York, Oxford University Press, 1998. 
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than examine, bioethical thinking.
13
 As Roger Cooter has pointed out, “Contemporary 
medical ethicists…constitute a part of the historical problem” rather than the 
solution.
14
  
 
1967: A responsibility that the College cannot shirk 
As Laura Stark has shown, in 1966, the idea of some sort of ethical peer review of 
research prior to it taking place was not new, and had been in place in the Clinical 
Centre of the US National Institutes of Health since its beginnings in 1953. The 
purpose of such ‘Group Consideration’ (as this review was called) was to emphasise 
the good standing of research at the Clinical Centre, and to insulate its work from 
oversight and interference by policymakers and lawyers at the NIH. The Medical 
Board which put this system in place clearly wanted an alternative to the ‘ethical code’ 
approach embodied in the Nuremburg Codes which were “not intended to discipline 
the majority of investigators, but to discredit the rare and egregious abuser”. Rather 
they “had in mind a more routine type of human subjects protection that, unlike the 
adoption of an abstract code, would be part of everyday practice and thus would not 
imply that they might doubt the honor of their colleagues”.15 The origins of ethical 
peer review of research lie not in the knee-jerk reaction of policymakers and 
bureaucrats to some research scandal, but in the realms of professional social control. 
                                                 
13
 E.g. Rothman D J Strangers at the Bedside: A history of how law and bioethics transformed medical 
decision making,  New York, Basic Books, 1991 
14
 Cooter R ‘Review article: The resistible rise of medical ethics’ Social History of Medicine, 1995, 
8(2): 257-270 on p.270. 
15
 Stark  (2006) op. cit. note 10, p.48 
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As Stark suggests, the “Group Consideration guidelines bear the marks of having 
been written by investigators for investigators”.16 
 
The obvious question then is one of timing: given that the idea of such review had 
been around for over a decade, why did it come to prominence in the UK in 1967, as 
opposed to any other time? The 1960s were clearly a time of reflection on the ethics 
of clinical research and broader medical practice, both on the part of professionals and 
the public. While, as Jenny Hazelgrove suggests, the Nuremberg Code of 1947 may 
have been largely ignored by British researchers
17
, ethical concerns on the part of  
various medical researchers had not gone away in the post-war years, and had 
prompted various institutional responses. The best example of this is the debate within 
the MRC over the role of informed consent. In 1954 the MRC canvassed unit 
directors on the correct treatment of human subjects in medical experiments; the 
directors, with rare exception, rejected the Council’s suggestion that written consent 
should be sought from patients enrolled in research, claiming that such a formal 
approach would undermine the trust at the heart of the doctor-patient relationship. 
This position, downplaying written at the expense of verbal consent, fed into formal 
MRC policy, and was included in the Council’s statement on ‘Responsibility in 
Investigations on Human Subjects’ published as part of the Councils’ 1962-63 Annual 
report.
18
 
                                                 
16
 Ibid. p.56 
17
 Hazelgrove, op. cit. (2002) note 2. 
18
 Medical Research Council, ‘Responsibility in Investigations on Human Subjects’, in Report of the 
Medical Research Council for the year 1962-1963 (HMSO: London), 1964, pp.21-25. For a detailed 
exploration of the origins of this report see: Bolton T. Consent and the Construction of the Volunteer: 
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That old, paternalistic, certainties were being questioned is emphasised in the debate 
in 1963 over informed consent in the British Medical Journal sparked by the 
publication of a lecture, on ‘Medical ethics and Controlled trials’, by Sir Austin 
Bradford Hill one of the founding fathers of the clinical trial. In this piece, Bradford 
Hill mounted an attack on the draft code of ethics on human experimentation which 
had recently been drawn up by the World Medical Association (the code became the 
‘Declaration of Helsinki’19), criticising its requirement for informed consent in all 
cases: “Surely it is often quite impossible to tell ill-educated and sick persons the pros 
and cons of a new and unknown treatment versus the orthodox and known?”.20 The 
article generated a scathing response from Helen Hodgson, Chair of the newly formed 
Patients Association (PA) – “It is astonishing to a layman to read a commentary on 
medical ethics which appears to advocate a doctor/patient relationship based upon 
deceit”21 – and letters defending Bradford Hill and Hodgson in turn.22 The debate was 
closed, not with the tacit acceptance of Bradford Hill’s paternalistic position but 
rather a highly critical editorial, suggesting that “If any proof were need of the 
                                                                                                                                            
Institutional Settings of Experimental Research on Human Beings in the Cold War, unpublished PhD 
Thesis, University of Kent, 2008. 
19
 World Medical Association. Ethical Principles for Medical Research Involving Human Subjects, 
1964, (Helsinki: World Medical Association). 
20
 Bradford Hill A. ‘Medical Ethics and Controlled Trials’ British Medical Journal 1963, April 20, 
pp:1043-1049 on p.1046 
21
 Hodgson H. ‘Letter: Medical Ethics and Controlled Trials’ British Medical Journal, 1963, May 18, 
pp.1339-1340 on p.1339 
22
 Murley RS ‘Letter: Medical Ethics and Controlled Trials’ British Medical Journal, 1963, June 1, 
pp.1474; Grimshaw PN ‘Letter: Medical Ethics and Controlled Trials’ British Medical Journal, 1963, 
June 29, pp.1736. 
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necessity for devising a code of ethics on human experimentation it was” Bradford 
Hill’s “dangerous” and, with regard to his arguments against the WMA’s draft code,  
“somewhat specious” ideas.23  
 
Such unity between the editors of an establishment journal such as the BMJ and a new 
pressure group, like the PA, underlines the breadth of concern about the ethics of such 
research in the early 1960s. In terms of public awareness of these issues, perhaps the 
pre-eminent figure of this time was Maurice Pappworth, who in a 1962 article for the 
literary magazine Twentieth Century, and 1967 book (both called Human Guinea 
Pigs), blew the whistle on what he felt were unethical research practices in both the 
UK and US, and who suffered intense public criticism from other doctors as a result.
24
 
Yet while this context explains why researchers and medics might have been 
receptive to the idea of research ethics review, it does not explain why RECs appeared 
when they did.  
 
The most obvious explanation, in accordance with the idea that REC development is 
pushed by some form of ‘moral panic’, gives prominence to Pappworth, and his 
                                                 
23
 Anon. ‘Editorial: Ethics of Human Experimentation’ British Medical Journal, 1963, July 6, pp.1-2  
24
 Pappworth MH ‘Human Guinea Pigs: A warning’ The Twentieth Century, Autmun 1962. pp.68-71; 
Pappworth MH Human Guinea Pigs: Experimentation on Man, ([1967] 1969) London, Penguin;  
Pappworth MH ‘”Human Guinea pigs” – a history’ British Medical Journal 1990, 301:1456-1460; 
Booth C. ‘Obituary: Maurice Pappworth’ British Medical Journal 1994, 1994;309:1577-1578; Lock, S 
‘Obituary: Dr Maurice Pappworth’ The Independent November 12, 1994, page 42; Edelson PJ ‘Henry 
K. Beecher and Maurice Pappworth: Honor in the development of the ethics of human 
experimentation’ , in V Roelcke and G Maio (eds.) Twentieth Century Ethics of Human Subjects 
Research, Stuttgart, Fran Steiner Verlag, 2004, pp. 219-233.  
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whistleblowing activities.
25
 Yet while Pappworth was a major figure in the broader 
British debates around medical ethics and research, he played only a marginal role in 
the development of research ethics committees. Rather than his 1967 suggestion that 
hospitals needed committees to oversee the ethics of research
26
 attention rather needs 
to turn to a memo from the US Surgeon General from the previous year to all 
recipients of grants from the US Public Health Service (PHS). This memo confirmed 
that in order to remain in receipt (or to get new) PHS grants for clinical research, 
applicants’ institutions had to provide prior review “of the judgment of the principal 
investigator” in terms of “the rights and welfare of the individual…of the 
appropriateness of the methods used to secure informed consent, and …of the risks 
and potential medical benefits of the investigation”.27 
 
As a consequence of this, at a number of leading UK teaching hospitals, where 
researchers were in receipt of such grants, ad hoc committees sprang up, as British 
researchers attempted to remain eligible for US funding. Dissatisfaction with the 
disorganised nature of the situation led Desmond Laurence, Fellow of the Royal 
College of Physicians, to approach Max Rosenheim, President of the Royal College of 
Physicians of London (RCP) (and Professor of Medicine at University College 
Hospital of which Laurence was a member). Max Rosenheim told Laurence to recruit 
two senior Fellows of the College distinguished for their research in different areas to 
                                                 
25
 Hazelgrove, op. cit. (2004), note 2 above, p.191. 
26
 Pappworth ([1967] 1969) op.cit note 24, p.252. 
27 Office of the Surgeon General (1966) ‘Investigations involving human subjects, including clinical 
research’ Memo to the Heads of Institutions Receiving Public Health Service Grants from the Surgeon 
General, 1 July 1966. Policy and Procedure Order 129. 
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write to him formally at the RCP.
 28
 Laurence was joined by Professor Tony 
Dornhorst and Sir Francis Avery Jones and the letter sent in September 1966, outlined 
the problem, pointing out that such committees were already being formed and that “it 
seems unlikely that they [the committees] will feel they can sensibly confine their 
attentions solely to cases where research is sponsored by a foreign country”. There 
was thus a need for some organisation to “undertake to consider whether the present 
supervisory arrangements for human experimentation, or the lack of them, are 
satisfactory” and the RCP, given its access to senior researchers and clinicians, and its 
ability to balance the interests of society at large with the needs of medical knowledge 
was “peculiarly suited to consider actively the whole of this important topic.”29 
 
By the end of October, Rosenheim had replied to the three physicians, pointing out 
that the topic of human experimentation had been discussed by the College a number 
of times and that further guidance in this area “is clearly a responsibility to the public 
that the College cannot shirk, and I am bringing your letter to the notice of the 
Council at its next meeting.”30 By January, the President had decided to set up a 
committee of the college to consider this issue
31
, and in May 1967, the Committee on 
the Ethical Supervision of Clinical Investigations in Institutions (of which all three 
signatories of the original letter were members) met for the first time. 
                                                 
28
 Interview, Desmond Laurence, July 2007. 
29
 Royal College of Physicians Archive (hereafter RCP), Letter to Professor Max Rosenheim, President 
Royal College of Physicians from F. Avery Jones, A.C. Dornhorst and D.R Laurence, 5 September 
1966.  
30
 RCP, Letter from Max Rosenheim to from F Avery Jones, AC Dornhorst and DR Laurence, 24 
October 1966. 
31
 RCP Archive, Letter from Registrar of RCP to FA Jones, 9 January 1967. 
 13 
 
The Committee reported in July 1967, producing two pages of commentary and 
recommendations, the most important of which was that each hospital authority had 
“a responsibility to ensure that all clinical investigations carried out within its hospital 
or institution are ethical and conducted with the optimum technical skill”. The way to 
do this was to ensure “that all projects were approved by a group of doctors including 
those experienced in clinical investigation”, although, given the variation of practices 
and interests between different institutions, the Committee refrained from giving 
detailed guidance on how these bodies should operate.
32
 
 
A number of key points emerge from the College’s report. The first is that, although 
public concern about medical research was widespread, specific scandals did not 
initiate the move towards ethics review.
33
 Rather, RECs were first mooted in the UK 
as a response on the part of professional medical researchers to funding requirements 
from the US PHS. This point is even clearer when one considers the MRC’s response 
to the RCP report. While Sir Harold Himsworth, Secretary of the MRC, approved of 
                                                 
32
 Royal College of Physicians of London (1967) Report of the Committee on the Supervision of the 
ethics of Clinical Investigations in Institutions (London: RCP), page 4. 
33
 Years later Desmond Laurence wrote to Pappworth, pointing out that although the RCP report 
predated Pappworth’s recommendations concerning RECs in his book, “I have no doubt your 1962 
article prepared people’s minds for it, including mine when I drafted the letter signed by Dornhurst and 
Avery Jones in 1966”: Wellcome Trust Archive, PP/MHP/c/5, Letter from Desmond Laurence to 
Maurice Pappworth, 10 May 1990. This point was reiterated to me in an interview with Laurence in 
July 2007. 
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the report – “I can say straightaway that I like it and agree with it”34 – there was little 
need for the Council to concern itself with setting up RECs, since most of its research 
would be carried out in NHS institutions with their own committees.
35
 Yet the lack of 
an ethics committee at the MRC funded National Institute for Medical Research 
(NIMR) became a problem a few months later in the Spring of 1968, when it became 
clear that the NIH was unwilling to fund the visit of a Colonel Kaufman to collaborate 
with researchers at the NIMR, unless some for of ethics review of the research could 
be provided.
36
 The solution was to set up an ethics committee within the context of 
the NIMR, the role of which was to review applications from the MRC’s ‘non-clinical’ 
centres and the Institute itself.
37
 International ‘echoes’ of the impact of the Surgeon 
Generals memo can be found in Sweden, where the first ethics committee was started 
in 1966 at the Karolinska institute, for exactly the same reasons.
38
  
 
It is also worth noting, not just that the RCP report does not offer a role for lay 
members on the proposed committees (something that Pappworth could exploit 
                                                 
34
 National Archives, Kew (hereafter NA), FD 9/869, Letter from Harold Himsworth to Max 
Rosenheim, 22 June 1967. 
35
 Although the MRC debated the issues raised by the report for its practices and policies: NA, FD 
9/869, Memo to Sir Harlod (Himsworth), 20 October 1967. 
36
 NA, FD 9/869, Letter from Brandon Lush to Sir Peter Medawar, 9 April 1968. The opportunistic, 
researcher-led nature of the setting up of this committee is supported by the fact that in the Autumn of 
1970, the NIMR committee was closed down, partly because it had so little work to do: NA, FD 9/869, 
Memo from Brandon Lush, 30 September 1970. 
37
 NA, FD 9/869, Letter from Brandon Lush to JS Weiner, 30 April 1968. 
38
 Westman-Naeser S ‘Current experiences in the Nordic Countries’ in P Bennett (ed.) Good clinical 
practice and ethics in European drug research, Bath, Bath University Press, 1994, pp. 27-35 
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following the publication of his book a few months later
39
) but also that the report 
places responsibility for the ethical conduct of research on the ‘competent authority’ 
of a hospital (i.e. its Board of Governors, Hospital Management Committee or 
Medical School Council) – an issue which was soon to cause considerable concern on 
the part of the Ministry of Health (MH). 
 
Response to the RCP report 
Following the publication of the report and its announcement in the British Medical 
Journal
40
 the Patients’ Association – set up in January 1963 in direct response to 
Pappworth’s original 1962 allegations41 – responded with cautious optimism, 
welcoming the idea of prior review by a group of doctors “provided such groups 
would not at any time include doctors involved in the project under consideration”. 
Yet the Association’s main point was to endorse “the placing of responsibility for 
ensuring that investigations are ethical and conducted with optimum skill and safety 
on the hospital authority” (emphasis added).  They noted that while an ethics 
committee might be able to assess the possible risks and benefits of clinical 
experiment, “This still leaves the question of whether the project is carried out in an 
ethical way”, especially with regard to informed consent. Thus for the Patients’ 
                                                 
39
 Pappworth MH ‘Letter: Experiments on Man’ British Medical Journal 2 September, 1967, 3(5565): 
616. 
40
 Rosenheim M ‘Supervision of the Ethics of Clinical Investigations in Institutions’ British Medical 
Journal 1967 12 August 3(5562): 429-430. 
41
 Wellcome Trust Archive PP/MHP/C.1/6. Letter from Helen Hodgson to Maurice Pappworth c. 
March 1963. 
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Association, the ultimate responsibility for the ethical conduct of research lay with the 
hospital, rather than the doctor.
42
 
 
Initially, the Ministry of Health was supportive of the College’s report, for it came at 
a time when they were under considerable pressure over the issue of human 
experimentation. Pappworth’s 1962 article and 1967 book had caused unease on the 
part of members of the public, and the Patients’ Association had applied constant 
pressure on the Ministry of Health though a campaign of letter writing and 
Parliamentary Questions from sympathetic MPs.  
 
In 1967, just prior to the publication of the RCP report, the Ministry’s response was to 
re-issue the 1962-1963 Medical Research Council’s (MRC) annual report, which 
addressed issues of research on humans and especially the need for fully informed 
consent.
43
 In the letter to consultants that accompanied the report Sir George Godber, 
the Chief Medical Officer, emphasised a theme than came to underpin the Ministry’s 
position with regard to the impending RECs, that the “real safety of patients of course 
rests securely upon the ethical standards of the profession” and the letter itself “is not 
intended to trespass upon these in any way or to purport to give guidance from the 
Ministry”.44 
 
                                                 
42
 National Archives, Kew (hereafter NA), MH 160/883 Letter from Helen Hodgson to Rt. Hon. 
Kenneth Robinson, Minister of Health, 18 August 1967.  
43
 MRC, op. cit. note 18. 
44
 NA, MH 160/883, Letter from GE Godber to All consultants in the Hospital Service ref: H/R125/22, 
17 July 1967. 
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The RCP report arrived soon after this and provided a useful opportunity for the 
Ministry to prove that it was taking these issues seriously. Yet it also presented 
officials with a number of problems. Like the Medical Board of the NIH’s Clinical 
Centre over a decade earlier, the Ministry accepted the limits of ethical codes and saw 
ethics review in principle as a “form of practical machinery as opposed to written 
guidance”, a form of machinery that meant that “ethical responsibility for approving 
experiments would rest with doctors”. Yet, 
“What is puzzling is the view [of the RCP] that the creation of such 
supervisory bodies would discharge the responsibility of the ‘competent 
authority’ [e.g. The Hospital Board] to ensure that all clinical investigations 
are ethical…which the Committee contend is necessary” 
The core of the issue was that Hospital Boards were not made up solely of doctors, 
but were predominantly lay, and since “Even if there were to be lay representation on 
these bodies [i.e. RECs], their understanding of the minutiae which might be the crux 
of the ethical problem in a particular case would necessarily be limited.” Thus, given 
these limits to lay understanding within RECs, “the suggestion that responsibility for 
such experiments should be put on the shoulders of the ‘competent’ lay authority is 
very questionable”. Therefore “it is essential that ethical and legal responsibility 
should be kept firmly on the shoulders of the medical profession (where it lies at the 
moment)”.45  
 
The key point underpinning this attitude is what Rudolph Klein calls the “bargain 
between the State and the medical profession” concerning clinical autonomy. In the 
original 1948 settlement that created the NHS, such autonomy, “the right of individual 
                                                 
45
 NA, MH 160/883, Memo from MR Edwards to Mr Morris, ref: H.S.1A A517, 25 August 1967. 
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doctors to do what they thought right for individual patients”,46 was secured at the 
cost of allowing economic decisions to be taken at a political level. Within the 
Ministry of Health, this ‘arms length’ attitude regarding individual clinical decisions 
extended to other area of medical practice, including clinical research. Thus some 
officials took exception to the Patients’ Association’s interpretation of the RCP report 
(that competent authorities are ultimately responsible for the ethics of research) since 
“it runs counter to the line we have taken on clinical investigations – that the decision 
to carry them out and the getting of true consent are medical matters coming within 
the responsibility of the doctor concerned”. While such authorities had a duty to 
ensure, when recruiting staff, that doctors had the appropriate qualifications, “they 
have no responsibility for oversight of the detailed clinical work undertaken by the 
doctor once appointed”.47 One obvious solution was for such committees “not […to…] 
be a sub-committee of the H.M.C. [Hospital Management Committee] but an informal 
body to whom the doctor proposing an experiment should refer for advice. The setting 
up of such committees would be a matter for the doctors themselves”.48 
 
The Ministry’s concerns about the RCP report were not just founded on the issue of 
clinical autonomy. There was also the matter of whether hospitals (and the broader 
NHS) would become, at least partly, liable for mistakes that occurred during clinical 
research.
49
 The political problems associated with who was responsible for unethical 
research in NHS hospitals had already been noted in June 1967, when in reference to 
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concerns raised by Pappworth’s book, the CMO noted that ultimately “The Minister 
can’t escape the point that the things complained of may be done in the hospitals for 
which he is responsible, but none of us wants this to get to the point where there could 
be any suggestion of making rules about it from here”.50 Thus, if correctly positioned 
within the NHS hierarchy, RECs could provide a means of public reassurance, while 
avoiding incurring liabilities for hospitals and infringing clinical autonomy. 
 
Thus within the Ministry, while concerns were also raised over liability issues should 
a nurse involved in a research project make a mistake
51
 or what should happen in the 
case where hospitals actively funded research, rather than just employ the doctors 
carrying it out,
52
 it was the twin concerns – the importance of clinical autonomy and 
the need to protect hospitals from liability – that led to disagreement over whether 
RECs should be formally set up by the hospital management or whether they should 
remain informal medical bodies. The resulting draft circular recommending the RCP 
report to hospitals was written in such a way as to “avoid bringing out too boldly the 
difference of opinion between us and the Royal College on the ‘competent authority’s’ 
responsibilities”.53  
 
Within a month, a solution was beginning to form that the answer to the problem of 
the ethical responsibilities of competent authorities lay not in trying to accommodate 
the RCP’s position but rather in highlighting the errors present in the committee’s 
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recommendations. Thus while the RCP Committee’s “suggestion that a group of 
doctors should be set up to advise on experiments” was useful, “we are agreed that the 
Cttee [sic.] are mistaken in their view…that hospital authorities have a responsibility 
to ensure that clinical investigations are ethical and are carried out with the optimum 
degree of skill and safety”. Any circular to hospitals “should correct the impression 
they give”.54 While some officials were reluctant to go into this kind of detail in a 
circular – “we are surely under no obligation to accept or comment on every sentence 
of the report”55 – the general consensus was that while: 
“the situation we want to create is that it is recognised that doctors should not 
undertake these experiments without submitting them first to a group of their 
colleagues…[at the same time]…neither the hospital authority nor the group 
[i.e. REC] is however responsible for the experiment and that the doctor 
cannot hide behind either”.56 
 
In the end, there was no need for a public disagreement with the Royal College. The 
Chief Medical Officer, Sir George Godber, contacted Sir Max Rosenheim, President 
of the RCP and Chair of the Committee on the Ethical Supervision of Clinical 
Investigations in Institutions. Sir Max agreed with the CMO’s interpretation that the 
Committee “were trying to say that the hospital authority had a responsibility to see 
that appropriate machinery was available for the guidance of doctors undertaking 
clinical investigations…[but]…They did not mean to go further and suggest that the 
Board or Committee should satisfy itself about the conduct of individual 
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investigations”.57 By the time the Ministry’s circular was being re-drafted, this 
‘reinterpretation’ of the RCP report had become the standard line, with Ministry of 
Health officials eventually being confident enough to tell representatives from 
Teaching hospitals that “what the [RCP] committee wanted to say was that the 
competent authority has a responsibility to see that appropriate machinery is available 
for the guidance of doctors” and thus “It is the firm view in the Department that the 
Committee’s intention should be followed rather than their words” (emphasis 
added).
58
 
 
1968: Recommending the report 
The Ministry then began the process of preparing to print off thousands of copies of 
the RCP report to send to consultants and hospitals, along with the still undecided 
circular note, recommending the report.
59
 The actual wording of the circular caused 
considerable debate among officials. Given that the note’s purpose was to recommend 
the RCP report to consultants and hospital managements, and that the circular was to 
be distributed with copies of the Report there was obviously the delicate matter of 
how to point out that the Ministry did not endorse the wording of the Report with 
regard to the responsibilities of competent authorities. While some officials sought to 
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acknowledge the differences with the RCP report
60
, the Minister of Health at the time, 
Kenneth Robinson, felt that such an admission went “unnecessarily far in inviting 
trouble” and suggested its omission.61 Ministry officials were acutely aware of the 
possible problems arising from the contrast between the RCP report and the circular – 
“it may excite Press comment and will certainly cause a reaction from the Patients 
Association” – and had asked that the Minister to be made aware of this 
disagreement.
62
 There were even concerns among some as to whether the Circular 
should be sent to consultants at all since “although we may ‘interpret’ the report for 
hospital authorities (our creatures) we should not do so for consultants who are 
independent”.63 
 
The final version of the Circular, numbered HM68(33), introduces the RCP report, 
and then reminds readers of the MRC annual report of 1962/63 and its focus on ‘true 
consent’ and how the getting of such consent “must clearly be the responsibility of the 
doctor who is to conduct it”. The third paragraph notes that the Report suggests that 
hospitals are responsible for ensuring “that facilities exist by which clinical 
investigations…are subject to appropriate scrutiny” and that “to this end they should 
secure that a group of doctors…is set up and that projects are subject to the approval 
of this group”. The final piece in the separation of ethical responsibilities is the 
statement that “It is envisaged that the groups would be informal advisory bodies 
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rather then committees of hospital authorities”.64 Thus in three short paragraphs the 
Circular embodies not just the Ministry’s view (in contrast to the letter of the RCP 
report) that clinical autonomy and liability issues devolve ethical responsibility for the 
conduct of research to individual doctors, but also that RECs must be distanced from 
formal association with hospitals. 
 
By the 3
rd
 of May the Ministry had alerted Senior Administrative Medical Officers 
(SAMOs) across the country that it would be sending out letters, circulars and copies 
of the RCP report to all consultants
65
 and ten days later thousands of papers were sent 
out for SAMOs and Teaching hospitals to distribute.
66
 By the 16
th
 of May the Patients 
Association had responded to the Circular in a way that, for Officials “comes as no 
surprise”.67 The Association felt that simply asking hospitals to implement the RCP 
report failed to meet any of the concerns raised in its letter of the previous August. In 
particular, the Association emphasised the inadvisability of “placing final 
responsibility on the hospital authority while instructing it to rely entirely on the 
medical groups”. Even the colour of the Circular was wrong: “it is universally 
understood in hospital administrative circles that only pink circulars need be acted 
upon and white circulars are liable not to be read”.68 For the Association, HM68(33)’s 
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pale complexion was an indication of how lightly the Ministry took the issues of 
human subjects protection. The Ministry’s response was to play a straight bat, reject 
the idea that there was a colour-based hierarchy for circulars and clearly spell out its 
position regarding the responsibilities of different groups regarding medical research: 
“though a hospital authority has power to permit experimental activities in its 
hospitals…it has no responsibility for oversight of the detailed clinical work 
done by a doctor once appointed”.69 
 
For the Ministry, the Circular provided a timely tool in its response to wider public 
concerns about medical experimentation. Newspaper reports about medical research 
led members of the public to ask “What sort of country are we getting to be to allow 
the old and the helpless to be shockingly exploited in this way”, drawing comparisons 
with “Hitler’s gas chambers” and noting that “For too long so-called scientists have 
been having a field day”.70 The standard reply could now refer, not just to the MRC 
Annual report from 1962-63 (and it’s re-circulation to doctors in mid-1967) but also 
to the RCP report and its wide distribution across the Health Service.
71
 
 
Compared to the Patients Association, the response from the medical profession and 
NHS was more positive. By early July, 500 more copies of the Circular had been 
ordered, and by August the Ministry, having distributed 25,000 copies of the RCP 
report was obliged to order 5000 more, of what was clearly a “best seller”72, to allow 
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distribution to Scotland. Yet the issue of the responsibilities of Hospital Management 
would not go away. A letter from Springfield Hospital in Tooting, in November 1968, 
suggests that members of hospital management committees were not satisfied with 
merely ensuring that a REC was set up but that they felt “a particular responsibility to 
patients and it is their opinion that any projects, although approved by the medical 
staff, should also be approved by them”.73 In reply the Ministry (now the Department 
of Health and Social Security – the DHSS) sought to quash any such ideas on the part 
of hospital management, repeating the position made to the Patients Association 
earlier in the year that, in essence, “Clinical decisions are for the clinician to make: 
ethical questions are for the profession to consider…it would not be in patients’ 
interests if hospital authorities were to interfere”.74  
 
1969-1970: Following Up 
Towards the end of 1969, Max Rosenheim approached the CMO, with the suggestion 
that the RCP, with the Department’s approval, should instigate some form of 
questionnaire ‘follow up’ to its report of two-years earlier.75 Godber’s reply was 
supportive – “I’m sure it would be a good idea” – and while the CMO was open to the 
idea of the Department itself carrying out some form of enquiry through the regional 
hospital boards, given the (apparently) independent nature of the original report he 
thought “there was some advantage in the follow up also being seen to be yours and 
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independent” albeit with Departmental help.76 Godber’s preference for the RCP to 
produce this information was to prove, in the long run, unhelpful, and, as the 
Department came under increasing pressure (particularly from the Patients 
Association) it would find itself having not only to defend the RCP’s data, but also to 
repeat much of its work. 
 
The RCP and the Department were not the only organisations that thought that some 
kind of review of the new REC system was needed. In March 1970, the Patients 
Association wrote to the Department of Health asking whether committees had been 
set up in accordance with the RCP report, whether they were reporting to hospital 
authorities, and whether these authorities were taking “an overall responsibility”.77 In 
discussing the reply to this letter, officials felt that, by and large, the Association 
could be referred back to the Ministry’s previous positions but the realisation that the 
Ministry could not maintain it’s arms length relationship with RECs (via the RCP) 
was dawning. It was clear that if hospital authorities were responsible for setting up 
RECs then “we for our part cannot abandon responsibility for knowing what they are 
doing”, and that if the ongoing RCP survey could not provide this information, “we 
should perhaps consider finding out for ourselves”.78 
 
The reply to the Association simply mentions that the RCP were following up their 
report and that “When we hear from them the results of their investigations we shall 
                                                 
76
 NA, MH 160/884, Letter from George Godber to Max Rosenheim, 31 October 1969. Godber clearly 
thought that the RCP would “get better co-operation from doctors themselves than the Department 
would”: NA, MH 160/884, Memo from GE Godber to Dr Yellowlees & Dr Cohen, 31 October 1969. 
77
 NA, MH 160/884, Letter from Helen Hodgson to PR Molineux, 11 March 1970. 
78
 NA, MH 160/884, Memo 47 from DJ Clark to Mr Molineux 21 April 1970. 
 27 
know the answer to your question on the setting up of committees”.79 The PA 
maintained a tenacious pursuit of these results, sending letters in June, October and 
November 1970 to find out whether the RCP had reported back
80
, refusing to be put 
off by claims that the RCP faced the “enormous task” of analysing and collating the 
replies and that the Department could not say when the results would be available.
81
 
In its strongly worded November letter, the PA suggested that it was “unreasonable 
that four years later [i.e. after the RCP report] there is no information available as to 
what action has been taken”, and urged the Department to obtain its own data on 
RECs.
82
 
 
This letter produced an immediate response from the DHSS with a letter going off the 
same day to the Royal College of Physicians asking for “some indication as to when 
the results of this enormous task are likely to be available?”83 leading to a 
commitment from the RCP to let the Department know when the report might be 
produced.
84
 By early 1971, even other parts of government, the Scottish Home and 
Health Department for example, were asking the DHSS how it was following-up the 
1968 circular.
85
 Pressure also came from the Peel Advisory Group which had been set 
up in 1970 to investigate issues around fetal research, and which was expected “to 
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place heavy reliance on the ethical committees set up under HM(68)33 as a means of 
controlling future fetal research”. The expectation was that if the RCP survey showed 
that response to the Circular had been inadequate, “the Peel Group will probably feel 
bound to make some recommendation in their report urging that urgent steps be taken 
to ensure that these committees are set up and work effectively”.86 
 
In May 1971, the Royal College of Physicians finally released its report
87
 to the 
Department, although the College pointed out that the report was “for limited release” 
and “should not be allowed to get into the hands of the Press”.88 Overall, the College 
and the Department probably had reason to feel satisfied. The 345 questionnaires that 
went out produced a 58% response rate, split between an 86% response from teaching 
hospitals and a 55% response from Regional Hospital Boards (i.e. non teaching). Of 
the 32 teaching hospitals that replied, 30 had ethics committees in place, one was in 
the process of forming one and the other in reforming one that had lapsed. Of the 169 
non-teaching hospitals that replied, 125 had committees in place, and 44 had not. 
While these figures may have given some comfort to the Department, some of the 
detail in the survey was perhaps more worrying. As the summary put it: “certain 
replies gave reason to suppose that the function of an Ethical Committee in screening 
research projects for the protection of the public, the institution, and the research 
worker is not yet universally accepted”. The main problem was “a particularly 
common belief that there are two sorts of clinical investigation, one of which requires 
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ethical supervision and the other of which does not, and that it is transparently easy to 
tell the one from the other”. 89 This is clear from the survey which suggests that in 
only 74% of replying hospitals with RECs in place, were all clinical investigations 
referred to the ethics committee. Even more worrying, in two hospitals, clinical drugs 
trials were given as an example of the kind of studies which did not require 
committee approval. 
 
Perhaps most interestingly in terms of the long term effects of the RCP survey, 
although it is not flagged up in the summary, is the information the report offers on 
the membership of RECs. Question 5 of the survey asked hospitals to indicate “the 
constitution of your Committee, giving total Membership, and numbers of medically 
qualified members, non-medical scientists and other members”; of the 126 hospitals 
that replied to this question, 101 had committees with only medical members, and of 
the 30 committees in teaching hospitals, only six had lay members. In the rare cases 
where non-teaching hospitals had lay members, they were always the Hospital or 
Group secretary. No committee had more than two lay members.
90
 While the actual 
response to this question might seem mild, the intriguing fact is that it is here at all. 
The 1967 RCP report made clear that ethics committees should be made up of medics 
alone, and, as we shall see, the inclusion of this question and these results puzzled the 
Department of Health when it came to its own deliberations about the results of this 
survey. 
 
1971: after the survey 
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In the meantime, the Patient’s Association had clearly decided to cut out the middle 
men, and approach hospitals directly to enquire about the presence, or otherwise of 
Research Ethics Committees. On the 24
th
 of May 1971, the Association sent out 
letters to a number of hospital boards, enquiring about the number of “ ‘ethical 
committees’ [that] have been established in the hospitals under your Board” as well as 
“how their membership is chosen and how they function”.91 As a result, a number of 
hospitals contacted the Department for advice on what to say in reply. For many 
officials the response to an increasingly provocative Patients Association seeking 
access to a survey that was deemed to be confidential was not obvious.
92
 One solution 
was to ask the RCP for permission to release the survey
93
 although this was rejected 
by some in the Department because since the survey showed that the “RCP’s original 
report is not yet universally accepted”, the survey itself was not suitable for release to 
the Association; indeed “it would be difficult for the RCP to extract those parts which 
are suitable”.94 In the middle of August events overtook officials when it became clear 
that “PA is in possession of the whole [survey] and the question of release of certain 
elements of the enquiry to them appears to be no longer pertinent”.95  
 
What was not immediately obvious was that the release of the whole document to the 
PA had taken place at the beginning of June, on the advice of Sir George Godber, the 
Chief Medical Officer. In a letter to Max Rosenheim of the RCP, Godber suggested 
that “it seems highly likely that a copy of it [the survey] or an extract from it will 
                                                 
91
 NA, MH 160/884, Letter from U Miller, no addressee, 24 May 1971. 
92
 NA, MH 160/884, Memo 1 from GRA Gill to Mr Smith, 11 June 1971. 
93
 NA, MH 160/884, Memo 2 from Mr Smith to Dr Archibald, 30 June 1971. 
94
 NA, MH 160/884, Memo 6 from Dr McGregor to Dr Archibald, 20 July 1971. 
95
 NA, MH 160/884, Memo 9 from Mr Yates to Miss Wavish, 13 August 1971. 
 31 
eventually reach Mrs. Hodgson [the then President of the PA]” in which case the 
Association “would certainly make whatever use of it it wished”.  A better alternative, 
Godber suggested, would be “to volunteer a copy, asking Mrs. Hodgson not to publish” 
and thus gain some sort of control over how the Association used the results of the 
survey.
96
 Rosenheim clearly agreed with this approach: later correspondence between 
the RCP and PA points out that while the Association can discuss the survey with the 
DHSS, and while the fact that a review had been carried out was not confidential, “the 
report itself is still regarded as a confidential document”.97  
 
In the middle of this debate, the issue of the range and number of RECs in the country 
became public, when, on the 27
th
 of July, Joyce Butler MP asked the Secretary of 
State “how many hospital authorities have now established and ethical 
committee…and how many committees include lay members”?98 It is unclear from 
the archives what the relationship was between Mrs. Butler and the Patients 
Association, but, given the timing (the PA would have received the RCP survey 
sometime in the previous ten days) and the constraints on what the PA could say 
about this confidential document, getting a sympathetic MP to ask about the results of 
the survey (without mentioning it in name) is a useful way of bringing the results into 
public domain. 
 
The written response to Mrs. Butler’s question blandly reassured Parliament that 
“some 55% of all hospital boards responded…and that nearly all teaching hospitals 
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and more than three quarters of others have now established such committees”. The 
Patients Association reacted angrily to this reply, since it misrepresented some of the 
data in the survey giving the impression of more RECs being in place than was the 
case.
99
 The Department accepted its error – apparently the result of a last minute edit 
of the written reply
100
, and while it wrote to Mrs. Butler to apologise and correct the 
information
101, felt that the Association’s reaction had been overblown.102 The 
Association itself was far from satisfied. In October 1971 it noted that Sir George 
Godber had just been quoted in the Guardian newspaper repeating the erroneous 
figure of 55% of non-teaching hospitals having ethics committees (when, of course, 
55% refers to the survey response rate), sarcastically asking whether, “If the 
Department is incapable of interpreting the survey, could not some assistance be 
given to it?”.103 
 
It seems likely that the timing and the tone of the Association’s letter were provoked 
by more public revelations (which the Association refer to obliquely in their letter) 
regarding the treatment of patients by medical researchers in the NHS. On Wednesday 
the 13
th
 of October (the day before the PA letter) Dr. John MacRae, a GP based in 
Fulham in London, named four London Hospitals at which he said that unethical 
research was being carried out. MacCrae was speaking out in support of Maurice 
Pappworth who, on a radio programme the previous Sunday, had made allegations 
about the treatment of patients at the Hammersmith and Royal Free hospitals. 
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MacCrae (who had been tutored by Pappworth) claimed that patients of his had been 
subjected to unnecessary investigations at Charing Cross, Westminster, University 
College and St. Thomas’s hospitals, all of which denied his claims, citing both the use 
of informed consent procedures and the approval of the hospitals’ ethics committees 
prior to any research.
104
 
 
In its own terms, Department officials knew that they could defend themselves against 
the PA’s objectsions. The Department was confident in its approach to RECs and 
respect for professional autonomy, reminding Secretaries of the boards of London 
hospitals that its policy was “to encourage the establishment of ethical 
committees…[and to]…rely upon the well established ethical practices of the 
profession and the sanctions which the profession itself imposes”. With regard to the 
allegations made by Pappworth and MacCrae, unless details could be provided about 
specific cases, the Secretary of State had to accept the denials of the hospitals 
accused.
105
 Yet at the same time, there was an acceptance among officials that they 
had to know what was actually going on in terms of implementing the 1968 Circular, 
and that because of the limited response to the RCP survey, this data was still lacking:  
“we shall continue to be in a somewhat indefensible position on all matters 
relating to experiments if we do not discover quickly the extent to which 
hospital authorities have implemented the…Guidance given in HM(68)33 to 
set up ethical committees.”  
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Thus there was a pressing need to contact Regional Health Boards to compile lists of 
HMCs that had set up committees, when they had been set up and their composition, 
as well as clarifying with those that had not yet set any committees up, whether there 
was intention to do so.
106
 This position was supported within the Department – “we’ll 
never exorcise this spectre until we get a reply from all hospital authorities”107 – 
although the need to seek permission from Max Rosenheim to repeat the RCP’s work 
was pointed out, and duly received.
108
 
 
At the same time, in late 1971, Parliament responded to the latest allegations about 
medical research with an adjournment debate on the 3
rd
 of November. Such debates 
are called by MPs at relatively short notice (usually a week) to respond to pressing 
concerns, and take place at the end of the day, after main Parliamentary business has 
finished. This debate, on ‘Hospital Patients (Experiments)’ was called by William 
Molly, MP for Ealing North, who had asked a number of PQs on this topic in the past, 
and who had corresponded with the Department previously. The central themes of 
Molloy’s impassioned speech were both that abuses of National Health Service 
patients appeared to have taken place and that the government was unwilling to 
launch a public enquiry into these events. Drawing on news reports of Pappworth’s 
recent radio interview, as well as private correspondence from patients and families 
who claimed to have undergone such experiments, Molloy noted that “the nation is 
disturbed” and called for a public enquiry.109 In response, Michael Alison, the Under-
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Secretary of State for Health and Social Security, agreed that the public should be 
disturbed by such allegations, but that the trouble lay in their unsubstantiated nature. 
Referring to Pappworth, Alison noted that “the author of the allegations…has, I 
understand, not been prepared to support them with specific evidence. Certainly I can 
say that my Department has not been supplied with any such evidence.” In addition, 
important structures, such as the MRC Annual report, were now in place to protect 
patients, and ensure informed consent. When it came to ethics committees, the 1967 
RCP report was refereed to as a good example of the responsible behaviour of the 
profession. That said the College’s survey produced information that was “not 
complete and my Department is therefore making its own inquiries of hospital 
authorities in England – the results of which I shall be happy to make known to the 
hon. Member, as soon as they are available”.110 
 
Thus, two years after the CMO suggested that the RCP survey the state of UK RECs 
independently of the Department, a Minister of health had to make a public 
commitment to carrying out exactly the same kind of work. The resulting enquiries, 
labelled ‘DS 308/71’ started on the 10th of November with a letter sent to Hospital 
boards, and by late December 1971 the results had been collated and analysed. Of the 
321 hospitals covered by the Regional Hospital Boards the Department approached, 
238 had ethics committees of some sort, 32 had decided that they did not need a 
committee and 51 were still debating the issue. In terms of different kinds of hospital, 
“all teaching hospitals have total cover. On the least favourable reading of the returns 
                                                 
110
 Michael Alison, Adjournment debate, 3 November 1971, Hansard Vol 825, No. 2, col. 324-328.  
 36 
just under 70% (69.8%) of HMCs [i.e. non-teaching] have complete cover; on the 
most favourable reading the percentage is 75.4%”.111  
 
These results are generally in line with the RCP report, but the Department’s analysis 
of its own and the RCP’s survey highlights a peculiar change in the College’s position 
with regard to lay members. The Department’s survey followed the RCP in asking 
about the membership of committees: the DS 308/71 results suggest that 187 out of 
the 238 committees were made up of only medical members. Yet officials were 
confused as to why the RCP survey (which the Department mimicked) had asked 
about lay members at all, since the original 1967 RCP report had not mentioned lay 
members, indeed it had defined RECs in terms of exclusive medical membership. “It 
is curious, therefore, to find them in their 1971 survey assessing the number of ethical 
committees with lay members without attempting to relate this to their 1967 
viewpoint”. Since in drafting its Circular, the Ministry of Health had followed the 
College’s lead in suggesting that RECs consist of medical personnel, “it will be 
difficult to suggest to hospital authorities that absence of lay members makes an 
ethical committee unsatisfactory”.112 
 
So where did this interest in lay members come from? Speculation on the part of 
DHSS officials focused on the 1967 report and its suggestion – later rejected by Max 
Rosenheim of course – that hospital authorities (made up of lay members) should take 
ultimate responsibility for the ethics of clinical investigations: 
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 “possible reason for the RCP apparent change of view, viz that they became 
confused about the intention behind the wording of Recommendation 2 of 
their Committee’s 1967 Report; that that Committees [sic] always intended 
that the hospital authority should play a major part in the oversight of clinical 
investigations; and that this is the reason for their interest in lay membership 
in their 1971 survey. Indeed, para 2 of the Survey’s Summary (page 1) is 
unequivocal in its statement of the hospital authority’s essential responsibility 
in the matter”.113 
The RCP’s survey summary does indeed refer to the original 1967 report as 
suggesting that “the responsible authority would be able to assure itself of the ethical 
propriety of every project for clinical research to be carried out there – something it 
had a duty to do”.114 The problem for the Department was that “It is not clear whether 
the wording of this question reflected any change of view on the part of the RCP as to 
how these committees should be composed, nor as far as I am aware, do we know 
what further consideration the RCP have given to the whole subject”.115 
 
This apparent volte face on the part of the College (or return to its original position) 
was problematic for the Department, since, as we have seen, the RCP’s ‘medics only’ 
policy for RECs was an important part of the official, arms-length position with 
regard to these committees. If one removed the support of the RCP for medical only 
RECs, then in turn the lay membership of such committees would undermine the 
official position that such research was too complex for lay people − meaning 
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members of hospital authorities − to understand. In turn this would put pressure on the 
argument that such authorities could not take responsibility for research, and in turn 
undermine the Department’s maintenance of clinical autonomy and avoidance of legal 
liability. 
 
The unexplained origin of this interest in lay members (although the Patients 
Association had raised this as an issue on a number of occasions) presented a threat to 
the Department’s position, but one which could be ignored for the time being. Thus 
on January 28
th
 1972, Michael Alison issued his written answer to a question from 
William Molloy, noting that “all teaching hospital authorities and over 70 percent of 
other hospital authorities” had RECs in place, of which, around a fifth included a lay 
member.
116
 This expansion, not just in academic centres such as teaching hospitals, 
but also in over ⅔ of other hospitals emphasises the status of RECs as NHS bodies. 
While their origins might lie in the needs of academic researchers, RECs swiftly 
became incorporated into broader the NHS context. 
 
Conclusion: 
In a short period of time, the Ministry of Health and its successor oversaw the 
development and expansion of RECs in the UK from zero to 238 committees. 
Through the use of the Royal College of Physicians as a form of proxy, officials 
ensured the spread of such committees, which proved a useful defence against claims 
that ‘more should be done’ to protect human subjects, while at the same time 
protecting the concept of clinical autonomy and avoiding the need for hospitals to 
take responsibility for doctors’ research. This reliance upon the RCP had its limits: the 
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College’s lack of formal powers (compelling response) meant that its survey of RECs 
had to be repeated and officials found themselves trying to disentangle RECs from the 
College’s attitudes towards the need for hospitals (and hence the NHS and its 
Ministers) to take responsibility for committees’ decisions (and the research that they 
approved). Lay members of RECs thus became a problem in attempts to erect a 
barrier between lay hospital management boards and clinicians’ research. Early 1972 
saw the Department overseeing a REC system which, while impressive for its breadth 
and acceptance by the clinical community, was clearly in a state of flux and by no 
means finalised. 
 
The main contribution of this article is to emphasise the importance of the role of the 
Ministry of health in the early development of research ethics committees in the UK. 
Previous work has tended to overlook the role of the Ministry and, consequently, 
highlight the role of RECs as a form of – usually inadequate – self regulation.117 It is 
not that RECs were not a form of self-regulation, but rather that this informal status 
was not the result of laissez-faire ‘drift’ on the part of policy makers but rather a 
deliberate, active decision to dissociate these committees from NHS bodies and thus 
help preserve the idea of clinical autonomy. 
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